GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Valuation Rank

Nanexa AB (OSTO:NANEXA) Valuation Rank


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Nanexa AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanexa AB (OSTO:NANEXA) Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.